NEW YORK – Enzo Biochem reported after the close of the market on Wednesday that revenues for its fiscal year 2021 first quarter rose 42 percent year over year, driven by a 66 percent increase in revenues from its clinical lab business.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.